alexa Thomas J. Dilling | Moffitt Cancer Center
ISSN: 2155-9619

Journal of Nuclear Medicine & Radiation Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Thomas J. Dilling

Moffitt Cancer Center  
Biography

 Dr. Dilling's primary clinical focus is the radiotherapeutic treatment of thoracic malignancies. He is interested in the application of new technologies to the treatment of lung cancer, with the ongoing goal to improve treatment efficacy while minimizing untoward side effects. In particular, Dr. Dilling is interested in the use of stereotactic radiotherapy for the treatment of early-stage lung cancers, and is also interested in tumoral genetic mutations which might confer greater (or reduced) radiation sensitivity

Research Interest

 lung cancer

Publications

Motion Management in Stereotactic Body Radiotherapy

Geoffrey G. Zhang, Hsiang-Hsuan Michael Yu, Craig W. Stevens, Thomas J. Dilling, Sarah E. Hoffe, Eduardo G. Moros and Vladimir Feygelman

Review Article: J Nucl Med Radiat Ther 2012,S6-012

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords